ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 406666 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 406666; 2) Community: the network communities that were significantly associated with the response to NSC 406666; 3) Molecule: the relationships between components within communities and NSC 406666; 4) MDR: the compounds that were significantly associated with the NSC 406666.

NSC Compound Enrichment Correlation
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.021985875528875 0.13317814
NSC 757306 Pyrimethamine (USAN) 0.021985875528875 0.38342384
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0219858755288753 0.19192752
NSC 683905 Null 0.0222647526168988 0.10985027
NSC 727680 MMP-9/MMP-13 Inhibitor l CalBioChem Cat. No. 444252 0.0222647526168988 0.24961137
NSC 760951 Null 0.0222647526168988 0.13505488
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0223138217461954 0.33514158
NSC 11897 2-Methyl-3-hydroxy-1,4-naphthoquinone 0.0223138217461955 0.30882531
NSC 136037 AT 116, benzylamine salt 0.0223138217461955 0.070434781
NSC 304421 LEUROSINE-N-OXIDE 0.0223138217461955 -0.085493329
Total:53  Current:20    [First] [Prev] [Next] [Last]